PRECLINICAL ASSESSMENT OF TOPICAL TREATMENTS OF HERPES-SIMPLEX VIRUS-INFECTION - 5-PERCENT (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE CREAM

被引：13

作者：

FREEMAN, DJ

SACKS, SL

DECLERCQ, E

SPRUANCE, SL

机构：

[1] UNIV BRITISH COLUMBIA,DEPT MED,DIV INFECT DIS,VANCOUVER V6T 1W5,BC,CANADA

[2] UNIV UTAH,SCH MED,CTR INFECT DIS DIAGNOST MICROBIOL & IMMUNOL,SALT LAKE CITY,UT 84132

[3] CATHOLIC UNIV LEUVEN,REGA INST MED RES,B-3000 LOUVAIN,BELGIUM

来源：

ANTIVIRAL RESEARCH | 1985年 / 5卷 / 03期

关键词：

D O I：

10.1016/0166-3542(85)90049-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：169 / 177

页数：9

共 50 条

[21] ANALYSIS OF THE THYMIDINE KINASE OF A HERPES-SIMPLEX VIRUS TYPE-1 ISOLATE THAT EXHIBITS RESISTANCE TO (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE
WILBER, BAJ
DOCHERTY, JJ
JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 1743 - 1747
[22] COMPARATIVE METABOLISM OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE AND 1-BETA-D-ARABINOFURANOSYL-E-5-(2-BROMOVINYL)URACIL IN HERPES-SIMPLEX VIRUS-INFECTED CELLS
AYISI, NK
WALL, RA
WANKLIN, RJ
MACHIDA, H
DECLERCQ, E
SACKS, SL
MOLECULAR PHARMACOLOGY, 1987, 31 (04) : 422 - 429
[23] (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE (BVDU) INHIBITS PROCESSING OF HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) GLYCOPROTEINS
SIEGEL, SA
PRUSOFF, WH
FEDERATION PROCEEDINGS, 1985, 44 (06) : 1837 - 1837
[24] ORAL (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN SEVERE HERPES-ZOSTER
DECLERCO, E
DEGREEF, H
WILDIERS, J
DEJONGE, G
DROCHMANS, A
DESCAMPS, J
DESOMER, P
BRITISH MEDICAL JOURNAL, 1980, 281 (6249): : 1178 - 1178
[25] E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE VS INTERFERON IN THE SYSTEMIC TREATMENT OF INFECTION WITH HERPES-SIMPLEX VIRUS OF ATHYMIC NUDE-MICE
DECLERCQ, E
ZHANG, ZX
DESCAMPS, J
HUYGEN, K
JOURNAL OF INFECTIOUS DISEASES, 1981, 143 (06): : 846 - 852
[26] EVALUATION OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE(BRVUDR) AND 5-VINYL-1-BETA-D-ARABINOFURANOSYLURACIL (BRVARAU, VARAU) IN THE TREATMENT OF EXPERIMENTAL HERPES-SIMPLEX VIRUS TYPE-1 KERATITIS IN RABBITS - COMPARISON WITH (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE (BRVUDR)
TOPKE, H
GRAF, M
WUTZLER, P
HERRMANN, G
REEFSCHLAGER, J
ANTIVIRAL RESEARCH, 1988, 9 (04) : 273 - 280
[27] ACTIVATION OF LATENT HERPES-SIMPLEX VIRUS TYPE-2 INFECTION INVITRO REQUIRES A (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE-SENSITIVE GENE-FUNCTION
SCHECK, AC
WIGDAHL, B
RAPP, F
INTERVIROLOGY, 1987, 27 (03) : 121 - 129
[28] THE ANTIVIRAL SPECTRUM OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE
DECLERCQ, E
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 : 85 - 95
[29] MICROBIOLOGICAL SYNTHESIS OF 5-ETHYL-2'-DEOXYURIDINE AND (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE
KALINICHENKO, EN
BARAI, VN
BOKUT, SB
ROMANOVA, VV
ZINCHENKO, AI
HERRMANN, G
MIKHAILOPULO, IA
BIOTECHNOLOGY LETTERS, 1989, 11 (09) : 621 - 626
[30] INHIBITION OF SIMIAN VARICELLA VIRUS-INFECTION OF AFRICAN-GREEN MONKEYS BY (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE (BVDU)
SOIKE, KF
GIBSON, S
GERONE, PJ
ANTIVIRAL RESEARCH, 1981, 1 (05) : 325 - 337

← 1 2 3 4 5 →